Coffee Linked to Lower Liver Disease Risk

Coffee consumption was linked to a lower risk of serious liver disease and related mortality, according to data from the U.K. Biobank. The study, which followed participants for a median of 13 years, indicated that higher coffee intake correlated with greater protective effects.

Researchers analyzed data from over 490,000 participants in the U.K. Biobank, examining their coffee drinking habits and liver health outcomes. The findings suggest that individuals who drank five or more cups of coffee per day experienced the most significant reduction in the risk of developing liver fibrosis, cirrhosis, and hepatocellular carcinoma. This association held true even after accounting for other lifestyle factors such as alcohol consumption, smoking, and diet.

The study's authors, publishing in the journal *BMC Public Health*, noted that the protective effect appeared to be dose-dependent, meaning that the more coffee consumed, the lower the risk of liver-related issues. This observation supports previous research suggesting that compounds in coffee, such as antioxidants and anti-inflammatory agents, may play a role in safeguarding liver function. The specific mechanisms are still under investigation, but potential pathways include reducing oxidative stress and inflammation within the liver.

While the results are promising for coffee drinkers, the researchers emphasize that coffee should not be considered a treatment for liver disease. They recommend that individuals with existing liver conditions or concerns should consult with a healthcare professional for personalized advice. The study's findings contribute to a growing body of evidence highlighting the potential health benefits of moderate to high coffee consumption for liver health.